- 10
- 21 812
LTR Pharma
Australia
เข้าร่วมเมื่อ 22 ต.ค. 2023
LTR Pharma is an advanced clinical-stage biopharmaceutical company commercialising a rapid treatment for Erectile Dysfunction (ED) - SPONTAN®. ED is a serious and common medical problem causing significant impacts to both physical and psychological health. Learn more at ltrpharma.com.
Conversation Series | Myth busting about Erectile Dysfunction
LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung shares insights on the common misconceptions about the lived experience of Erectile Dysfunction; myths in relation to treatment of Erectile Dysfunction, his professional views on the particular issues around the context of men’s sexual health and why SPONTAN® will be welcomed as a potential solution for Erectile Dysfunction.
มุมมอง: 705
วีดีโอ
Conversation Series | Treatment Innovation for ED - Oral vs Nasal Delivery
มุมมอง 243หลายเดือนก่อน
LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung shares insights on nasal delivery; issues of first pass metabolism with oral medications; why speed to action and efficacy matters to patients in their assessment of appropriate treatments for Erectile Dysfunction; and the response to SPONTAN® from patients.
Conversation Series | 101 on Erectile Dysfunction (ED)
มุมมอง 3102 หลายเดือนก่อน
In this video, LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung, shares insights into Erectile Dysfunction (ED); an explanation of the erectile mechanism; how ED is caused; who it impacts (this one might surprise you); and the potential for SPONTAN® to help those with men’s health issues.
Conversation Series | Treatment Innovation for ED - Introduction to SPONTAN®
มุมมอง 1122 หลายเดือนก่อน
In this video, LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung shares insights on nasal delivery technology and why it is an effective pathway to treat erectile dysfunction; the innovation of SPONTAN®; a deep dive on clinical evidence to support the benefits and mechanism of action of SPONTAN®; and why patients are so interested in this new tre...
Conversation Series | Treatments for Erectile Dysfunction (ED)
มุมมอง 1653 หลายเดือนก่อน
In this third video in the series, LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung shares insights on what treatments are currently available for Erectile Dysfunction; an explanation on PDE5 inhibitors and the shortfalls of this medication class; and why there is such a pressing need for an on-demand treatment like SPONTAN®, which bypasses the ...
Conversation Series | Meet the Expert - Professor Eric Chung
มุมมอง 4015 หลายเดือนก่อน
In the first instalment of this 6-part series, we meet LTR Pharma's Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung.
Ausbiz | LTR Pharma | 4 March 2024
มุมมอง 3077 หลายเดือนก่อน
LTR Pharma Executive Chairman, Lee Rodne, discusses the Company's progress in the advancement of rapid treatment for Erectile Dysfunction (ED), SPONTAN®, including the commencement of recruitment for its pivotal bioequivalence study.
Ausbiz | LTR Pharma ASX Debut
มุมมอง 1329 หลายเดือนก่อน
LTR Pharma (ASX:LTP) Non-Executive Director, Dr Julian Chick, was interviewed on Ausbiz to discuss the Company's ASX debut.
LTR Pharma | Investor Webinar, ASX Listing Day
มุมมอง 1539 หลายเดือนก่อน
LTR Pharma Chairman, Lee Rodne, joined JMM Director, Jane Morgan, on an investor webinar today to officially launch the Company on the ASX under ticker code $LTP and to answer a variety of insightful questions. Take a look.
SPONTAN® | Novel Intranasal Technology
มุมมอง 20K11 หลายเดือนก่อน
LTR Pharma Ltd is developing SPONTAN® - novel intranasal delivery technology designed to treat Erectile Dysfunction (ED) in 10 minutes or less. Learn more: ltrpharma.com